These included the likes of it not being scalable, its lack of integration with existing technology such as bar codes, privacy issues, as well as often being very expensive.
However, Jeremy Friedler of Maxiom Group said that there has been a resurgence in the use of RFID technology in recent times, especially thanks to the fact that a swell in the number of chips sold has been reported by Impinj.
RFID is resurgent because it has the means within which to plug a gap in the market. That is to say that RFID can improve the efficiency and visibility thereof in the transportation of drugs, looking at integrity of temperature control and anti-counterfeit measures.
An uninterrupted flow of data between producer and customer also means an improvement in the likes of aftercare and other aspects of pharmaceuticals.
Friedler said that it showed what happens when time is taken over the use of new technology, adding that it "holds significant promise for the healthcare and life sciences industries, particularly with regards to the security and efficiency of pharmaceutical supply chains."
--Article contributed by Cold Chain IQ